The sales volume of transcatheter heart valves is increasing across several healthcare centers due to the growing prevalence of various heart diseases such as cardio valvular diseases, mitral regurgitation, and aortic stenosis require valve replacement.
Increasing mortality due to chronic and end-stage cardiovascular diseases in the elderly population is a key concern for the healthcare providers across the world. As per the American Heart Association estimates in 2017, nearly 19.1 million deaths occur each year due to various cardiovascular diseases. In the U.S., heart disease is a leading cause of death, accounting for approximately 375,000 deaths per year.
Rising geriatric population is leading to a significant burden on the healthcare system. As per the UN estimates, the geriatric population in the U.S. is expected to reach over 72 million by 2022. The growth of the target population coupled with growing risk of end-stage cardiovascular diseases is expected to improve the usage of these valves. Moreover, the benefits of minimally invasive surgeries and transcatheter heart valve implantation have been strongly advocated on the basis of PARTNER I and PARTNER II clinical trials.
The Transcatheter Heart Valves market was valued at xxx million USD with a CAGR xx% from 2015-2019. Subsequently, it will touch xxx million USD in 2020 with a CAGR xx % from 2020 to 2025.
In the global Transcatheter Heart Valves market, This report focuses particularly in North America, South America, Europe and Asia-Pacific, and Middle East and Africa. This report classifies the market on the basis of application, type, regions, and manufactures.
The following companies are covered:
Boston Scientific Corporation
ST. Jude Medical
Edwards Lifesciences Corporation
Colibri Heart Valve
On-X Life Technologies
Jenavalve Technology
Market Segment by Product Type
Transcatheter Aortic Valve
Transcatheter Pulmonary Valve
Transcatheter Mitral Valve
Market Segment by Application
Hospitals
Clinics
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Transcatheter Heart Valves market for the forecast period 2020 - 2025?
• What are the driving forces in the Transcatheter Heart Valves market for the forecast period 2020 - 2025?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Transcatheter Heart Valves industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?